Figure 3

Comparison of on-treatment HBeAg declines between patients with HBsAg loss and no HBsAg loss (A) at EOT. ROC curves of on-treatment HBeAg declines for the prediction of HBsAg loss (B) at EOT. HBsAg, hepatitis B surface antigen; EOT: end of treatment; ROC, receiver-operating characteristic.